Objectives: To determine the prevalence of controlled diabetes in registereddiabetic patients with Hemoglobin A1c (HbA1c) ≤ 7 or Fasting blood Sugar ≤ 130 mg/dl inthree primary Health Care Centers of Al- Ameer Ahmad Sector of Makkah. Methods: This studywas a descriptive study (cross sectional) started from 20 June 2012 to 30 September 2012. ThePrimary Health Care Centers randomly selected were AL-Zahir, Al-Hindavia and Kudai Al- Hijra.The sample size calculated was 320 patients with confidence level of 95% and confidenceinterval of 5. The cut of values adjusted for all diabetes mellitus patients was, haemogloblin A1c( HBA1c) ≤ 7 or fasting blood sugar (FBS) ≤ 130 mg/dl .Hypertension values were set as 140/90 mm of Hg. Results: Overall the age range was 25 – 87 (62) years and a mean of +/- SDof 58.66 +/- 11.97. Out of 320 diabetic patients selected (152 only diabetes + 168 patients ofdiabetes with hypertension) 21.25 % have disease under control. Most effected age range ofuncontrolled diabetes was 45-74 years. HbA1c test for study year was not done in 83.43 %cases. The age and Gender difference in two groups were not significant, however the resultsof controlled and non-controlled diabetic patients in three Primary Health Care Centers wassignificant (P <0.05 ). Conclusions: Diabetes Control programme at the level of Primary HealthCenters showed a very low level of success in study groups. There is a need to reconsider thecontrol strategy.
Objectives: Our aim was to determine the prevalence of controlled diabeteson the basis of HbA1c test (Hb ≤ 7 ) in registered diabetic population in three Primary HealthCenters of Ministry of Health Makkah al Mukarrahma. Study Design: Retrospective review ofmedical records of registered adult Saudi patients with type 2 diabetes. Setting: Three PrimaryHealth Centers of Ministry of Health Makkah al Mukarrahma. Period: 20 June 2015 to 31December 2015. Methods: The sample size calculated was 354 patients with confidence levelof 95% and confidence interval of 5. The cut of values adjusted for all diabetes mellitus patientswas, haemogloblin A1c (HBA1c) ≤ 7. Three last readings were recorded and to be declared ascontrolled diabetic case (valid control), last two readings were required to be within this normallimit. Data was processed on Microsoft Excel and SPSS-23 software. Results: Overall the agerange was 21–79 (58) years and a mean of +/- SD of 56.67 +/- 11.97. Male were 206 and female148 in number. Hb A1c test entries recorded in 292. On the basis of set HbA1c criteria no validcontrol entry was found in one PHC while in other two, there were 15 (4.23% prevalence) validcontrol entries. Valid control results were found significant (P < 0.05). Conclusion: Very lowPrevalence of controlled diabetes on bases of HbA1c test in Primary Health Centers indicatenoncompliance of this test in our study group. Guidelines of the Ministry of Health regardingcare of diabetic patients in Primary Health Care should be followed to achieve the recommendedoutcome.
ABSTRACT… Objectives: Our aim was to determine the prevalence of controlled diabetes on the basis of HbA1c test (Hb ≤ 7 ) On the basis of set HbA1c criteria no valid control entry was found in one PHC while in other two, there were 15 (4.23% prevalence) valid control entries. Valid control results were found significant (P < 0.05). Conclusion: Very low Prevalence of controlled diabetes on bases of HbA1c test in Primary Health Centers indicate noncompliance of this test in our study group. Guidelines of the Ministry of Health regarding care of diabetic patients in Primary Health Care should be followed to achieve the recommended outcome. Key words:HbA1c, Prevalence, Controlled Type2 diabetes, Primary Health Care Center.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.
hi@scite.ai
10624 S. Eastern Ave., Ste. A-614
Henderson, NV 89052, USA
Copyright © 2024 scite LLC. All rights reserved.
Made with 💙 for researchers
Part of the Research Solutions Family.